Atle Fund Management AB
CIK 1381843 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $371.7M
- Posisi
- 39
- Per tanggal
- 30 Juni 2026
#4.548 dari 9.443 berdasarkan nilai 13F · top 48.2%
Nilai portofolio QoQ: +20.0% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 48,00%
- Bobot 25 kepemilikan teratas
- 83,67%
- Posisi di atas 1%
- 33
- Jumlah posisi efektif
- 26,6
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 28,96% Perkiraan pembelian $98.661.342 · penjualan $289.214.085
Kepemilikan median: 5,0 kuartal Dilacak Q4 2024–Q2 2026 · 67,2% masih dipegang
- Posisi baru
- 3
- Meningkat
- 16
- Menurun
- 20
- Tertutup
- 3
Di halaman ini
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Rincian sektor
Healthcare
100,0%
Portofolio lengkap 39 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company Common Stock | $35.768.202 | 9,62% | 29.821 | $8.922.876 | Turun ×1 | ||
| MRK Merck & Company, Inc. Common Stock (new) | $24.332.374 | 6,55% | 189.357 | $1.415.205 | Naik ×1 | ||
| JNJ Johnson & Johnson Common Stock | $21.695.387 | 5,84% | 85.425 | $9.752.294 | Turun ×1 | ||
| ABBV AbbVie Inc. Common Stock | $16.186.743 | 4,35% | 64.325 | $5.800.944 | Turun ×1 | ||
| CVS CVS Health Corporation Common Stock | $15.114.251 | 4,07% | 146.102 | $5.847.030 | Naik ×1 | ||
| TMO Thermo Fisher Scientific Inc Common Stock | $13.967.388 | 3,76% | 27.859 | $-482.610 | Naik ×1 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $13.685.860 | 3,68% | 73.077 | $4.608.837 | Turun ×1 | ||
| BIIB Biogen Inc. - Common Stock | $13.564.462 | 3,65% | 62.781 | Naik ×1 | |||
| NBIX Neurocrine Biosciences, Inc. - Common Stock | $12.285.864 | 3,31% | 72.898 | $4.431.394 | Turun ×3 | ||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $11.801.475 | 3,17% | 100.807 | $2.403.935 | Turun ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $11.177.372 | 3,01% | 213.329 | $2.941.852 | Turun ×1 | ||
| IONS Ionis Pharmaceuticals, Inc. - Common Stock | $10.873.116 | 2,93% | 137.131 | $1.474.326 | Naik ×1 | ||
| ONC BeOne Medicines Ltd. - American Depositary Shares | $10.025.244 | 2,70% | 35.180 | $-2.111.919 | Turun ×1 | ||
| ISRG Intuitive Surgical, Inc. - Common Stock | $9.805.198 | 2,64% | 24.656 | $360.435 | Turun ×1 | ||
| SYK Stryker Corporation Common Stock | $9.534.299 | 2,57% | 30.283 | $-45.413 | Naik ×1 | ||
| VRTX Vertex Pharmaceuticals Incorporated - Common Stock | $9.502.941 | 2,56% | 19.131 | $-1.665.024 | Turun ×1 | ||
| EW Edwards Lifesciences Corporation Common Stock | $9.338.185 | 2,51% | 103.230 | $1.071.527 | Turun ×1 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $9.288.177 | 2,50% | 124.707 | $-2.605.304 | Naik ×1 | ||
| KRYS Krystal Biotech, Inc. - Common Stock | $8.927.141 | 2,40% | 24.019 | $2.133.325 | Turun ×1 | ||
| COR Cencora, Inc. Common Stock | $8.808.035 | 2,37% | 31.126 | $2.204.813 | Naik ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $8.433.458 | 2,27% | 248.848 | $2.925.178 | Naik ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $7.751.734 | 2,09% | 58.170 | $2.968.138 | Naik ×1 | ||
| INCY Incyte Corporation - Common Stock | $6.456.192 | 1,74% | 56.953 | $-1.517.936 | Naik ×1 | ||
| IRTC iRhythm Holdings, Inc. - Common Stock | $6.435.432 | 1,73% | 54.102 | $175.770 | Naik ×1 | ||
| BSX Boston Scientific Corporation Common Stock | $6.247.541 | 1,68% | 146.381 | $-2.596.695 | Naik ×1 | ||
| INSM Insmed Incorporated - Common Stock | $6.224.262 | 1,67% | 58.378 | $269.191 | Turun ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $6.206.891 | 1,67% | 198.557 | $2.577.313 | Naik ×1 | ||
| GILD Gilead Sciences, Inc. - Common Stock | $5.829.580 | 1,57% | 46.142 | $-1.326.930 | Turun ×3 | ||
| CAH Cardinal Health, Inc. Common Stock | $5.613.542 | 1,51% | 23.630 | $845.332 | Turun ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $5.223.500 | 1,41% | 54.886 | Naik ×1 | |||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $5.063.123 | 1,36% | 57.030 | $1.577.316 | Turun ×1 | ||
| DXCM DexCom, Inc. - Common Stock | $4.838.828 | 1,30% | 71.846 | $2.198.905 | Turun ×1 | ||
| BCAX Bicara Therapeutics Inc. - Common Stock | $4.324.556 | 1,16% | 145.657 | $2.009.321 | Turun ×1 | ||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $3.521.195 | 0,95% | 94.478 | $-490.299 | Naik ×1 | ||
| CELC Celcuity Inc. - Common Stock | $3.485.206 | 0,94% | 33.313 | $-1.656.002 | Turun ×1 | ||
| IRON Disc Medicine, Inc. - Common Stock | $3.194.901 | 0,86% | 43.682 | $6.214 | Turun ×1 | ||
| PYXS Pyxis Oncology, Inc. - Common Stock | $2.909.041 | 0,78% | 966.459 | $1.290.988 | Naik ×1 | ||
| CMPX Compass Therapeutics, Inc. - Common Stock | $2.296.418 | 0,62% | 1.048.593 | $-754.637 | Naik ×1 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $1.967.714 | 0,53% | 88.556 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| JNJ | Dipangkas | -7K | +$9.8M |
| LLY | Dipangkas | -10K | +$8.9M |
| CVS | Beli lebih banyak | +122K | +$5.8M |
| ABBV | Dipangkas | -44K | +$5.8M |
| RVMD | Dipangkas | -544K | +$4.6M |
| NBIX | Dipangkas | -17K | +$4.4M |
| ABVX | Beli lebih banyak | +27K | +$3.0M |
| ALKS | Dipangkas | -29K | +$2.9M |
| NAMS | Beli lebih banyak | +154K | +$2.9M |
| BBIO | Beli lebih banyak | +13K | -$2.6M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| AMGN | 30 Juni 2026 | 21.903 | $8.716.028 | 20,5% |
| ITCI | 31 Maret 2025 | 71.138 | $5.938.600 | Tidak lagi dilacak |
| UFPT | 31 Maret 2026 | 22.986 | $5.103.581 | 59,6% |
| VRNA | 30 Sep. 2025 | 47.100 | $4.454.718 | Tidak lagi dilacak |
| FOLD | 31 Maret 2025 | 326.840 | $3.075.564 | Tidak lagi dilacak |
| UNH | 30 Juni 2026 | 14.636 | $2.772.424 | -5,6% |
| ACLX | 31 Maret 2026 | 41.717 | $2.719.948 | Tidak lagi dilacak |
| AUTL | 31 Maret 2026 | 1.169.634 | $2.327.571 | 79,0% |
| SLNO | 30 Juni 2026 | 90.184 | $2.207.336 | Tidak lagi dilacak |
| CRBP | 31 Maret 2026 | 107.255 | $873.055 | 4,9% |
| MRSN | 31 Maret 2025 | 538.621 | $764.842 | Tidak lagi dilacak |
| PHVS | 31 Maret 2025 | 34.328 | $652.919 | 132,6% |
| EW | 31 Des. 2025 | 65.659 | $542.105 | 7,7% |
| MRUS | 31 Des. 2025 | 47.999 | $479.766 | Tidak lagi dilacak |
| HRMY | 31 Des. 2025 | 92.074 | $269.397 | 5,5% |
| CABA | 30 Juni 2025 | 182.354 | $252.560 | 101,1% |
| RNA | 31 Des. 2025 | 51.978 | $240.427 | -81,1% |
| SMMT | 31 Des. 2025 | 92.737 | $203.404 | -28,1% |
| MREO | 31 Des. 2025 | 764.901 | $167.282 | -26,3% |
| JANX | 31 Des. 2025 | 49.820 | $129.265 | 26,1% |